Impact of Coaching Patients on Pain Control With and Without Financial Incentivization

The Economy of Pain: A Pilot Study of the Impact of an Opioid Buyback Program

Opioids are commonly prescribed pain medications, but they can lead to addiction. The study team is trying to determine if providing someone with an incentive (money in the form of a Visa gift card) to use less pain medications will result in study participants actually using fewer pain tablets than allowed by their health care provider. The study team also wants to know if providing the incentive (the Visa gift card alone) works the same as the incentive (the Visa gift card) plus providing additional information about addiction and alternative pain management.

Study Overview

Detailed Description

Study participants will receive the standard of care for pain management at discharge. If study participants were not hospitalized at discharge, the study team will begin that standard of pain management at the participant's first outpatient clinic visit. Study participants will be randomized to 1 of 3 groups. All groups will receive a gift card if participants return the completed medication diary to the study team.

  • Group 1 will complete a medication diary. Also, group 1 will be encouraged to return any unused tablets to the study clinic.
  • Group 2 will be asked to complete a medication diary. Group 2 will also have a 50/50 chance of receiving money for each unused opioid tablet returned to the study clinic.
  • Group 3 will be the same as group 2 except in addition, they will be given a coaching session about the use of pain medication and a simple way that may help participants use less opioid pain medication.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients suffering from a burn injury of one or both hands/upper extremities
  • Patients staying less than 2 midnights after date of injury or presenting for first visit to the clinic 4 or less days after injury
  • Patients able to self-administer their oxycodone.
  • Aged 18-89 years old

Exclusion Criteria:

  • No burns on either hand or upper extremity
  • Patients suffering chemical or electrical burns
  • Patients with other traumatic injuries for which they might require opioids/pain treatment
  • Patients taking opioids prior to injury
  • Patients who are discharged with prescriptions other than oxycodone with a dosage of 5 milligrams by mouth every six hours as needed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1--Diary and Possible Opioid Return Incentive
Participants in this arm will be given incentives upon return of completed diary and will have the possibility to earn incentives for returning any leftover tablets to the study team.
Subjects who return completed diary will have the possibility to receive money for returned opioid tablets.
Subjects who return completed diary will receive a gift card.
Experimental: Group 2--Diary, Coaching, Possible Opioid Return Incentive
Participants in this arm will be given coaching. They will also be given incentives upon return of completed diary and will have the possibility to earn incentives for returning any leftover tablets to the study team.
Subjects who return completed diary will have the possibility to receive money for returned opioid tablets.
Subjects who return completed diary will receive a gift card.
Subjects will receive coaching prior to starting pain medication.
Experimental: Group 3--Diary and coaching
Participants in this arm will be given coaching. They will also be given incentives upon return of completed diary.
Subjects who return completed diary will receive a gift card.
Subjects will receive coaching prior to starting pain medication.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mean number of opioid tablets used daily
Time Frame: up through two weeks
up through two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John K Bailey, MD, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2022

Primary Completion (Anticipated)

August 1, 2022

Study Completion (Anticipated)

August 1, 2022

Study Registration Dates

First Submitted

October 1, 2019

First Submitted That Met QC Criteria

October 1, 2019

First Posted (Actual)

October 2, 2019

Study Record Updates

Last Update Posted (Actual)

May 12, 2022

Last Update Submitted That Met QC Criteria

May 6, 2022

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00058073

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Opioid Use

Clinical Trials on Possible Incentive for Tablet Return

3
Subscribe